1. Home
  2. DEI vs RXRX Comparison

DEI vs RXRX Comparison

Compare DEI & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DEI
  • RXRX
  • Stock Information
  • Founded
  • DEI 1971
  • RXRX 2013
  • Country
  • DEI United States
  • RXRX United States
  • Employees
  • DEI N/A
  • RXRX N/A
  • Industry
  • DEI Real Estate Investment Trusts
  • RXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • DEI Real Estate
  • RXRX Health Care
  • Exchange
  • DEI Nasdaq
  • RXRX Nasdaq
  • Market Cap
  • DEI 2.4B
  • RXRX 2.4B
  • IPO Year
  • DEI 2006
  • RXRX 2021
  • Fundamental
  • Price
  • DEI $16.35
  • RXRX $4.89
  • Analyst Decision
  • DEI Buy
  • RXRX Buy
  • Analyst Count
  • DEI 8
  • RXRX 4
  • Target Price
  • DEI $18.43
  • RXRX $7.25
  • AVG Volume (30 Days)
  • DEI 1.4M
  • RXRX 17.0M
  • Earning Date
  • DEI 11-03-2025
  • RXRX 11-05-2025
  • Dividend Yield
  • DEI 4.65%
  • RXRX N/A
  • EPS Growth
  • DEI N/A
  • RXRX N/A
  • EPS
  • DEI 0.22
  • RXRX N/A
  • Revenue
  • DEI $1,001,173,000.00
  • RXRX $64,596,000.00
  • Revenue This Year
  • DEI $2.92
  • RXRX $24.09
  • Revenue Next Year
  • DEI $2.16
  • RXRX $20.99
  • P/E Ratio
  • DEI $75.41
  • RXRX N/A
  • Revenue Growth
  • DEI 3.24
  • RXRX 30.14
  • 52 Week Low
  • DEI $12.39
  • RXRX $3.79
  • 52 Week High
  • DEI $20.50
  • RXRX $12.36
  • Technical
  • Relative Strength Index (RSI)
  • DEI 54.47
  • RXRX 49.35
  • Support Level
  • DEI $16.06
  • RXRX $4.57
  • Resistance Level
  • DEI $16.62
  • RXRX $5.09
  • Average True Range (ATR)
  • DEI 0.38
  • RXRX 0.26
  • MACD
  • DEI -0.04
  • RXRX 0.05
  • Stochastic Oscillator
  • DEI 33.33
  • RXRX 70.98

About DEI Douglas Emmett Inc.

Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. It is an owner and operator of office and multifamily properties located in coastal submarkets in Los Angeles and Honolulu. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments, the office segment and the multifamily segment.

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Share on Social Networks: